$14.74
1.21%
Nasdaq, Apr 21, 07:48 pm CET
ISIN
IL0011595993
Symbol
INMD

Inmode Stock price

$14.92
-3.43 18.69% 1M
-2.29 13.31% 6M
-1.78 10.66% YTD
-2.53 14.50% 1Y
-15.02 50.17% 3Y
+2.71 22.19% 5Y
+8.14 119.90% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
+0.01 0.07%
ISIN
IL0011595993
Symbol
INMD
Sector

Key metrics

Market capitalization $1.04b
Enterprise Value $449.17m
P/E (TTM) P/E ratio 6.38
EV/FCF (TTM) EV/FCF 3.40
EV/Sales (TTM) EV/Sales 1.14
P/S ratio (TTM) P/S ratio 2.63
P/B ratio (TTM) P/B ratio 1.47
Revenue growth (TTM) Revenue growth -19.76%
Revenue (TTM) Revenue $394.82m
EBIT (operating result TTM) EBIT $112.53m
Free Cash Flow (TTM) Free Cash Flow $131.98m
Cash position $596.47m
EPS (TTM) EPS $2.34
P/E forward 8.58
P/S forward 2.65
EV/Sales forward 1.15
Short interest 11.68%
Show more

Is Inmode a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Inmode Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Inmode forecast:

3x Buy
43%
4x Hold
57%

Analyst Opinions

7 Analysts have issued a Inmode forecast:

Buy
43%
Hold
57%

Financial data from Inmode

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
395 395
20% 20%
100%
- Direct Costs 78 78
4% 4%
20%
317 317
23% 23%
80%
- Selling and Administrative Expenses 191 191
5% 5%
48%
- Research and Development Expense 13 13
2% 2%
3%
113 113
42% 42%
29%
- Depreciation and Amortization 0.73 0.73
18% 18%
0%
EBIT (Operating Income) EBIT 113 113
42% 42%
29%
Net Profit 181 181
8% 8%
46%

In millions USD.

Don't miss a Thing! We will send you all news about Inmode directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inmode Stock News

Positive
Seeking Alpha
18 days ago
I upgrade InMode to Buy due to improved capital allocation, including significant share buybacks and potential for record dividends. Despite a 20% revenue decline in 2024, InMode remains a strong cash generator, with $600 million in cash. Conservative DCF valuation suggests a fair value of $21.67 per share, implying a 22.5% potential upside from current levels.
Neutral
PRNewsWire
26 days ago
YOKNEAM, Israel , March 26, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer, and Yair Malca, Chief Financial Officer, will present at the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025.
Neutral
PRNewsWire
about 2 months ago
Clarifies Capital Allocation Strategy and Commitment to Shareholder Returns Refutes Misconceptions on Staffing and Production Asserts No Justification for Additional Legal Action YOKNEAM, Israel , March 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Management LLC ("DOMA")...
More Inmode News

Company Profile

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Head office Israel
CEO Moshe Mizrahy
Employees 599
Founded 2008
Website www.inmodemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today